312 results
Page 5 of 16
8-K
EX-99.1
loaxzzdq i2hp
14 Apr 21
Synthetic Biologics Announces First Patient Dosed in Phase 1b/2a Clinical Trial
7:01am
8-K
EX-99.1
oxk0z6fh 1ifwaas61m
1 Apr 21
Synthetic Biologics Announces First Six Participants Dosed in Phase 1a Clinical Trial of SYN-020 Intestinal Alkaline Phosphatase
7:01am
8-K
EX-99.1
gvcg8ibxkc7
4 Mar 21
Synthetic Biologics Reports 2020 Year End Operational Highlights and Financial Results
4:15pm
8-K
EX-1.1
4g8xz0h3tmj
10 Feb 21
Entry into a Material Definitive Agreement
6:00am
8-K
EX-99.1
6e32ot90eakww9pq pm
24 Nov 20
Synthetic Biologics Announces Extension of Compliance Plan Period by NYSE American
7:05am
8-K
EX-99.1
aqykpusbr74
12 Nov 20
Departure of Directors or Certain Officers
7:05am
8-K
EX-99.1
qaj0fp3ami
10 Nov 20
Synthetic Biologics Reports 2020 Third Quarter Operational Highlights and Financial Results
4:20pm
S-8
EX-4.12
6zl6 phlw
28 Oct 20
Registration of securities for employees
5:23pm
S-8
EX-4.13
o0b6ag847hir
28 Oct 20
Registration of securities for employees
5:23pm
S-8
EX-4.11
8eas11
28 Oct 20
Registration of securities for employees
5:23pm
8-K
EX-99.1
a93 b4konkon3jl6ypr
2 Oct 20
Synthetic Biologics Provides Update on Investigator-Sponsored Phase 2b Clinical Study
7:05am
8-K
EX-99
rymfgyzlm ov91q3fi
6 Aug 20
Synthetic Biologics Reports 2020 Second Quarter Operational Highlights and Financial Results
4:20pm
8-K
EX-99.1
w9lan3kx
5 May 20
Synthetic Biologics Reports 2020 First Quarter Operational Highlights and Financial Results
4:15pm